157 related articles for article (PubMed ID: 26489491)
1. Duration of dual antiplatelet therapy after coronary stenting.
Briasoulis A; Palla M
Int J Cardiol; 2016 Nov; 222():1064-1067. PubMed ID: 26489491
[No Abstract] [Full Text] [Related]
2. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery.
Refiker M
Am Heart J; 2011 May; 161(5):e25; author reply e27. PubMed ID: 21570501
[No Abstract] [Full Text] [Related]
3. Add-on Antiplatelet Effects of Eicosapentaenoic Acid With Tailored Dose Setting in Patients on Dual Antiplatelet Therapy.
Hosogoe N; Ishikawa S; Yokoyama N; Kozuma K; Isshiki T
Int Heart J; 2017 Aug; 58(4):481-485. PubMed ID: 28717113
[TBL] [Abstract][Full Text] [Related]
4. [Antiplatelet drugs - implications for the anesthesiologist].
Gogarten W; Van Aken HK
Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):242-51; quiz 252. PubMed ID: 22504621
[TBL] [Abstract][Full Text] [Related]
5. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
Yan BP; Gurvitch R; Ajani AE
Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
[TBL] [Abstract][Full Text] [Related]
6. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
Terpening C
J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
[TBL] [Abstract][Full Text] [Related]
7. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
8. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
9. A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Pecot CV; Fuller M; Muldowney JA; Misra S
Tenn Med; 2009 May; 102(5):37-9. PubMed ID: 19456028
[No Abstract] [Full Text] [Related]
10. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
Piamsomboon C; Laothavorn P; Chatlaong B; Saguanwong S; Nasawadi C; Tanprasert P; Leelaprute M; Intayakorn U; Amornsak N
J Med Assoc Thai; 2001 Dec; 84(12):1701-7. PubMed ID: 11999816
[TBL] [Abstract][Full Text] [Related]
11. Letter by Gasparovic et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Gasparovic H; Petricevic M; Biocina B
Circulation; 2011 Aug; 124(6):e193; author reply e195-6. PubMed ID: 21824930
[No Abstract] [Full Text] [Related]
12. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
Lee SW; Lee JY; Ahn JM; Park DW; Han S; Park YK; Lee WS; Jang JY; Kwon CH; Park GM; Cho YR; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2013 Dec; 112(11):1738-44. PubMed ID: 24063835
[TBL] [Abstract][Full Text] [Related]
13. Use of antiplatelet drugs after cardiac operations.
Ferraris VA; Bolanos MD
Semin Thorac Cardiovasc Surg; 2014; 26(3):223-30. PubMed ID: 25527016
[TBL] [Abstract][Full Text] [Related]
14. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
15. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
Bhatt DL
Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
[TBL] [Abstract][Full Text] [Related]
16. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
Geisler T; Zürn C; Simonenko R; Rapin M; Kraibooj H; Kilias A; Bigalke B; Stellos K; Schwab M; May AE; Herdeg C; Gawaz M
Eur Heart J; 2010 Jan; 31(1):59-66. PubMed ID: 19812059
[TBL] [Abstract][Full Text] [Related]
17. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
[TBL] [Abstract][Full Text] [Related]
18. Letter by Bisdas et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
Bisdas T; Haverich A; Teebken OE
Circulation; 2011 Aug; 124(6):e194; author reply e195-6. PubMed ID: 21824931
[No Abstract] [Full Text] [Related]
19. Dual antiplatelet therapy for coronary artery disease.
Lee CW
Circ J; 2015; 79(2):255-62. PubMed ID: 25744739
[TBL] [Abstract][Full Text] [Related]
20. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).
Redfors B; Ben-Yehuda O; Lin SH; Furer A; Kirtane AJ; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Généreux P; Giustino G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Ayele GM; Mehran R; Mintz GS; Stone GW
Am J Cardiol; 2017 Sep; 120(6):917-923. PubMed ID: 28754568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
